Chelonia Ongoing Projects
Advancing next-generation L1 REPETITIVE RNA platform in clinic first in human Hutchinson-Gilford PROGERIA syndrome.
Climate change: an enduring challenge for vector-borne disease prevention and control.
Mapping Immuno Dominant Antigens of Sars- CoV-2 to understand cell host response. Consortium joined by top qualified research centers in Italy, Switzerland, Luxembourg and The Netherlands.
This project is supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003551. Read more.
This project has received funding from the European High-Performance Computing Joint Undertaking Joint Undertaking (JU) under grant agreement No 956137. The JU receives support from the European Union’s Horizon 2020 research and innovation program and Italy, Sweden, Austria, Czech Republic, Switzerland. Read more.
MEDIATE (MOLECULAR DOCKING AT HOME)
In the framework of EXSCALATE4COV, this crowdsourcing initiative is aiming to find new therapeutic candidates against COVID together with research groups not already involved in other EU granted projects. Read more.
Thanks to the data provided by GISAID, and to the analysis on the SARS-CoV-2 sequences that we are carrying out within the EXSCALATE4COV project, we want to collect essential information and make it easily usable and accessible to the scientific community and beyond. Read more.
Microbiome diagnostics highlighting the health effect and robustness of patient's microbiome. Personalized dietary supplements improving microbiome composition to reduce the risk of selected diseases.
HLA and innate-immunity gene variants as severity predictors of COVID-19: an Italian multi-centric perspective association study.